Table 1.
Baseline | Tilt | P (circadian) | ||
---|---|---|---|---|
SBP (mmHg) | Peak phase | 231.7°±11.8° | 254.1°±9.6° | 0.0079 |
Trough phase | 340.7°±15.2° | 357.7°±9.4° | ||
| ||||
Peak-to-trough amplitude | 4.6±1.5 | 5.6±1.5 | ||
| ||||
Tilt effect | -2.6±0.6 | |||
| ||||
DBP (mmHg) | Peak phase | 233.3°±26.4° | 275.5°±9.1° | 0.012 |
Trough phase | 119.2°±27.4° | 173.6°±10.6° | ||
| ||||
Peak-to-trough amplitude | 1.9 ±1.1 | 3.9 ±1.1 | ||
| ||||
Tilt effect | 9.3 ±0.4 | |||
| ||||
HR (bpm) | Peak phase | 189.8°±24.4° | 177.0°±10.9° | <0.0001 |
Trough phase | 318.1°±22.5° | 55.0°±18.2° | ||
| ||||
Peak-to-trough amplitude | 5.9±2.2 | 8.9±2.2 | ||
| ||||
Tilt effect | 25.9±0.9 | |||
| ||||
SDNN (msec) | Peak phase | 35.6°±8.9° | 345.9°±19.0° | <0.0001 |
Trough phase | 265.0°±21.4° | 228.4°±14.1° | ||
| ||||
Peak-to-trough amplitude | 25.3±4.8 | 15.2±5.0 | ||
| ||||
Tilt effect | -25.5 ±2.0 | |||
| ||||
Epinephrine (pg/ml) | Peak phase | 217.2°±25.5° | 208.7°±11.7° | <0.0001 |
Trough phase | 328.7°±20.4° | 329.3°±9.0° | ||
| ||||
Peak-to-trough amplitude | 10.6±5.5 | 28.6±5.4 | ||
| ||||
Tilt effect | 25.0±2.2 | |||
| ||||
Norepinephrine (pg/ml) | Peak phase | 120.9°±28.9° | 202.3°±13.4° | 0.00023 |
Trough phase | 352.2°±36.9° | 324.5°±15.3° | ||
| ||||
Peak-to-trough amplitude | 40.7±20.8 | 81.7±21.1 | ||
| ||||
Tilt effect | 163.9±8.7 | |||
| ||||
RMSSD (msec) | Peak phase | 8.8°±25.3° | 113.8°±26.6° | 0.00048 |
Trough phase | 203.6°±29.7° | 221.7°±21.1° | ||
| ||||
Peak-to-trough amplitude | 17.9 ±4.2 | 8.6±5.0 | ||
| ||||
Tilt effect | -41.5±2.0 | |||
| ||||
pNN50 (%) | Peak phase | 5.7°±69.1° | 96.8°±48.5° | 0.0026 |
Trough phase | 188.3°±21.7° | 220°±43.7° | ||
| ||||
Peak-to-trough amplitude | 10.6 ±2.8 | 4.1±3.3 | ||
| ||||
Tilt effect | -31.9±1.4 |